533 related articles for article (PubMed ID: 22234990)
1. Predictors of emergency department and outpatient visits for hypoglycemia in type 2 diabetes: an analysis of a large US administrative claims database.
Simeone JC; Quilliam BJ
Ann Pharmacother; 2012 Feb; 46(2):157-68. PubMed ID: 22234990
[TBL] [Abstract][Full Text] [Related]
2. Risk factors for hypoglycemia-related hospitalization in patients with type 2 diabetes: a nested case-control study.
Quilliam BJ; Simeone JC; Ozbay AB
Clin Ther; 2011 Nov; 33(11):1781-91. PubMed ID: 22018449
[TBL] [Abstract][Full Text] [Related]
3. Baseline characteristic differences between patients prescribed sitagliptin vs. other oral antihyperglycemic agents: analysis of a US electronic medical record database.
Zhang Q; Rajagopalan S; Mavros P; Engel SS; Davies MJ; Yin D; Radican L
Curr Med Res Opin; 2010 Jul; 26(7):1697-703. PubMed ID: 20465367
[TBL] [Abstract][Full Text] [Related]
4. Hypoglycemia, treatment discontinuation, and costs in patients with type 2 diabetes mellitus on oral antidiabetic drugs.
Bron M; Marynchenko M; Yang H; Yu AP; Wu EQ
Postgrad Med; 2012 Jan; 124(1):124-32. PubMed ID: 22314122
[TBL] [Abstract][Full Text] [Related]
5. Persistence with injectable antidiabetic agents in members with type 2 diabetes in a commercial managed care organization.
Cooke CE; Lee HY; Tong YP; Haines ST
Curr Med Res Opin; 2010 Jan; 26(1):231-8. PubMed ID: 19921965
[TBL] [Abstract][Full Text] [Related]
6. The incidence and costs of hypoglycemia in type 2 diabetes.
Quilliam BJ; Simeone JC; Ozbay AB; Kogut SJ
Am J Manag Care; 2011 Oct; 17(10):673-80. PubMed ID: 22106460
[TBL] [Abstract][Full Text] [Related]
7. Risk of hospitalization for heart failure associated with thiazolidinedione therapy: a medicaid claims-based case-control study.
Hartung DM; Touchette DR; Bultemeier NC; Haxby DG
Pharmacotherapy; 2005 Oct; 25(10):1329-36. PubMed ID: 16185176
[TBL] [Abstract][Full Text] [Related]
8. Incidence and risk factors for serious hypoglycemia in older persons using insulin or sulfonylureas.
Shorr RI; Ray WA; Daugherty JR; Griffin MR
Arch Intern Med; 1997 Aug 11-25; 157(15):1681-6. PubMed ID: 9250229
[TBL] [Abstract][Full Text] [Related]
9. Comparisons of rosiglitazone versus pioglitazone monotherapy introduction and associated health care utilization in Medicaid-enrolled patients with type 2 diabetes mellitus.
Balkrishnan R; Arondekar BV; Camacho FT; Shenolikar RA; Horblyuk R; Anderson RT
Clin Ther; 2007 Jun; 29(6 Pt 1):1306-15. PubMed ID: 18036392
[TBL] [Abstract][Full Text] [Related]
10. Coronary heart disease outcomes in patients receiving antidiabetic agents.
McAfee AT; Koro C; Landon J; Ziyadeh N; Walker AM
Pharmacoepidemiol Drug Saf; 2007 Jul; 16(7):711-25. PubMed ID: 17551989
[TBL] [Abstract][Full Text] [Related]
11. Medication adherence and the associated health-economic impact among patients with type 2 diabetes mellitus converting to insulin pen therapy: an analysis of third-party managed care claims data.
Lee WC; Balu S; Cobden D; Joshi AV; Pashos CL
Clin Ther; 2006 Oct; 28(10):1712-25; discussion 1710-1. PubMed ID: 17157128
[TBL] [Abstract][Full Text] [Related]
12. The burden of hypoglycemia on healthcare utilization, costs, and quality of life among type 2 diabetes mellitus patients.
Williams SA; Shi L; Brenneman SK; Johnson JC; Wegner JC; Fonseca V
J Diabetes Complications; 2012; 26(5):399-406. PubMed ID: 22699113
[TBL] [Abstract][Full Text] [Related]
13. Risk factors associated with symptomatic hypoglycemia in type 2 diabetes mellitus patients.
Durán-Nah JJ; Rodríguez-Morales A; Smitheram J; Correa-Medina C
Rev Invest Clin; 2008; 60(6):451-8. PubMed ID: 19378831
[TBL] [Abstract][Full Text] [Related]
14. Adherence with pharmacotherapy for type 2 diabetes: a retrospective cohort study of adults with employer-sponsored health insurance.
Hertz RP; Unger AN; Lustik MB
Clin Ther; 2005 Jul; 27(7):1064-73. PubMed ID: 16154485
[TBL] [Abstract][Full Text] [Related]
15. The risk of myopathy associated with thiazolidinediones and statins in patients with type 2 diabetes: a nested case-control analysis.
Koro CE; Sowell MO; Stender M; Qizilbash N
Clin Ther; 2008 Mar; 30(3):535-42. PubMed ID: 18405791
[TBL] [Abstract][Full Text] [Related]
16. Risks of cardiovascular diseases associated with dipeptidyl peptidase-4 inhibitors and other antidiabetic drugs in patients with type 2 diabetes: a nation-wide longitudinal study.
Ou HT; Chang KC; Li CY; Wu JS
Cardiovasc Diabetol; 2016 Mar; 15():41. PubMed ID: 26932742
[TBL] [Abstract][Full Text] [Related]
17. Severe hypoglycemia is associated with antidiabetic oral treatment compared with insulin analogs in nursing home patients with type 2 diabetes and dementia: results from the DIMORA study.
Abbatecola AM; Bo M; Barbagallo M; Incalzi RA; Pilotto A; Bellelli G; Maggi S; Paolisso G;
J Am Med Dir Assoc; 2015 Apr; 16(4):349.e7-12. PubMed ID: 25669671
[TBL] [Abstract][Full Text] [Related]
18. Sulfonylurea monotherapy and emergency room utilization among elderly patients with type 2 diabetes.
Rajpathak SN; Fu C; Brodovicz K; Engel SS; Heaton PC
Diabetes Res Clin Pract; 2015 Sep; 109(3):507-12. PubMed ID: 26123984
[TBL] [Abstract][Full Text] [Related]
19. Risk of acute myocardial infarction in patients treated with thiazolidinediones or other antidiabetic medications.
Stockl KM; Le L; Zhang S; Harada AS
Pharmacoepidemiol Drug Saf; 2009 Feb; 18(2):166-74. PubMed ID: 19109802
[TBL] [Abstract][Full Text] [Related]
20. Race, ethnicity, and use of thiazolidinediones among US adults with diabetes.
Aquilante CL; Zhang W; McCollum M
Curr Med Res Opin; 2007 Mar; 23(3):489-94. PubMed ID: 17355730
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]